Photo of Asher A Chanan Khan

View Scopus Profile

Asher A Chanan Khan, MD

  • 10307 Citations
  • 50 Scopus h-Index
20012019

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Asher A Chanan Khan is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 35 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

A Phase I Study to Assess the Safety and Pharmacokinetics of Single-agent Lorvotuzumab Mertansine (IMGN901) in Patients with Relapsed and/or Refractory CD–56-positive Multiple Myeloma

Ailawadhi, S., Kelly, K. R., Vescio, R. A., Jagannath, S., Wolf, J., Gharibo, M., Sher, T., Bojanini, L., Kirby, M. & Chanan-Khan, A., Jan 2019, In : Clinical Lymphoma, Myeloma and Leukemia. 19, 1, p. 29-34 6 p.

Research output: Contribution to journal › Article

    • 8 Scopus citations

    Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 2.2019

    Wierda, W. G., Byrd, J. C., Abramson, J. S., Bilgrami, S. F., Bociek, G., Brander, D., Brown, J., Chanan Khan, A. A., Chavez, J. C., Coutre, S. E., Davis, R. S., Fletcher, C. D., Hill, B., Kahl, B. S., Kamdar, M., Kaplan, L. D., Khan, N., Kipps, T. J., Ma, S., Malek, S. & 9 others, Mato, A., Mosse, C., Neppalli, V. T., Shadman, M., Siddiqi, T., Stephens, D., Wagner, N., Dwyer, M. A. & Sundar, H., Jan 1 2019, In : JNCCN Journal of the National Comprehensive Cancer Network. 17, 1, p. 12-20 9 p.

    Research output: Contribution to journal › Article

    • 9 Scopus citations

    IGH translocations in chronic lymphocytic leukemia: Clinicopathologic features and clinical outcomes

    Fang, H., Reichard, K. K., Rabe, K. G., Hanson, C. A., Call, T. G., Ding, W. D., Kenderian, S., Muchtar, E., Schwager, S. M., Leis, J. F., Chanan Khan, A. A., Slager, S. L., Braggio, E. D., Smoley, S. A., Kay, N. E., Shanafelt, T. D., Van Dyke, D. L. & Parikh, S. A., Jan 1 2019, (Accepted/In press) In : American Journal of Hematology.

    Research output: Contribution to journal › Article

    • 2 Scopus citations

    Indatuximab Ravtansine (BT062) Monotherapy in Patients With Relapsed and/or Refractory Multiple Myeloma

    Jagannath, S., Heffner, L. T., Ailawadhi, S., Munshi, N. C., Zimmerman, T. M., Rosenblatt, J., Lonial, S., Chanan Khan, A. A., Ruehle, M., Rharbaoui, F., Haeder, T., Wartenberg-Demand, A. & Anderson, K. C., Jan 1 2019, In : Clinical Lymphoma, Myeloma and Leukemia.

    Research output: Contribution to journal › Article

    • 8 Scopus citations

    Long-Term Studies Assessing Outcomes of Ibrutinib Therapy in Patients With Del(11q) Chronic Lymphocytic Leukemia

    Kipps, T. J., Fraser, G., Coutre, S. E., Brown, J. R., Barrientos, J. C., Barr, P. M., Byrd, J. C., O'Brien, S. M., Dilhuydy, M. S., Hillmen, P., Jaeger, U., Moreno, C., Cramer, P., Stilgenbauer, S., Chanan-Khan, A. A., Mahler, M., Salman, M., Eckert, K., Solman, I. G., Balasubramanian, S. & 6 others, Cheng, M., Londhe, A., Ninomoto, J., Howes, A., James, D. F. & Hallek, M., Nov 2019, In : Clinical Lymphoma, Myeloma and Leukemia. 19, 11, p. 715-722.e6

    Research output: Contribution to journal › Article

    Open Access
    • 6 Scopus citations